| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 71,186 | 72,391 | 63,529 | 58,491 | | Cost of Revenue | 49,404 | 47,359 | 44,003 | 41,745 | | | Gross Profit | 21,782 | 25,032 | 19,526 | 16,746 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,451 | 11,056 | 10,092 | 8,182 | | Non Recurring |
-
|
-
|
-
| (840) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,331 | 13,976 | 9,434 | 9,404 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 44 | 107 | (50) | (115) | | Earnings Before Interest And Taxes | 11,375 | 14,083 | 9,384 | 9,289 | | Interest Expense | (89) | 83 | 18 |
-
| | Income Before Tax | 11,464 | 14,000 | 9,366 | 9,289 | | Income Tax Expense | 4,356 | 5,320 | 3,559 | 3,530 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,108 | 8,680 | 5,807 | 5,759 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,108 | 8,680 | 5,807 | 5,759 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,108 | $8,680 | $5,807 | $5,759 |
|
0.50% Nasdaq 
Income Statement
